| Title : (+-)-cis-2-methyl-spiro(1,3-oxathiolane-5,3')quinuclidine, an M1 selective cholinergic agonist, attenuates cognitive dysfunctions in an animal model of Alzheimer's disease - Fisher_1991_J.Pharmacol.Exp.Ther_257_392 |
| Author(s) : Fisher A , Brandeis R , Karton I , Pittel Z , Gurwitz D , Haring R , Sapir M , Levy A , Heldman E |
| Ref : Journal of Pharmacology & Experimental Therapeutics , 257 :392 , 1991 |
| Abstract : Fisher_1991_J.Pharmacol.Exp.Ther_257_392 |
| ESTHER : Fisher_1991_J.Pharmacol.Exp.Ther_257_392 |
| PubMedSearch : Fisher_1991_J.Pharmacol.Exp.Ther_257_392 |
| PubMedID: 2019998 |
Fisher A, Brandeis R, Karton I, Pittel Z, Gurwitz D, Haring R, Sapir M, Levy A, Heldman E (1991)
(+-)-cis-2-methyl-spiro(1,3-oxathiolane-5,3')quinuclidine, an M1 selective cholinergic agonist, attenuates cognitive dysfunctions in an animal model of Alzheimer's disease
Journal of Pharmacology & Experimental Therapeutics
257 :392
Fisher A, Brandeis R, Karton I, Pittel Z, Gurwitz D, Haring R, Sapir M, Levy A, Heldman E (1991)
Journal of Pharmacology & Experimental Therapeutics
257 :392